Liver cancer treatment is a rapidly evolving field, especially as new discoveries shed light on the complex relationships between bile acid metabolism and the onset of hepatocellular carcinoma (HCC).Recent research has uncovered a critical molecular switch that links disruptions in bile acid regulation to liver diseases, opening new avenues for therapeutic interventions.